Serum Institute of India (SII) has sought from India's drug regulator approval for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said.from IndiaTV India: Google News Feed https://ift.tt/2ZMiUn4
No comments:
Post a Comment
Please Leave us a comment about our content, so that we can try improve our site Quality.